Conversely, Makhlin et al (32) found that p-mTOR expression was increased in malignant versus normal urothelium in only 32% (65/203) of tumours, and no association with clinicopathological and outcome parameters was observed (32). The gene discussed is MTOR; the disease is neoplasm.